Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01561859 · ClinicalTrials.gov registry record · NA
Brain Imaging, Cognitive Enhancement and Early Schizophrenia
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 102
- Enrollment target
NCT01561859 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 102 participants.
The verdict
NCT01561859, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 102 participants
- Enrollment target
Study Summary
The proposed project is designed to examine the effects of cognitive rehabilitation on brain structure and function in a randomized trial of 102 early course schizophrenia patients treated for 18 months with either cognitive enhancement therapy (CET) or an Enriched Supportive Therapy (EST) control, and then followed-up at 1-year post-treatment.
Interventions
- BEHAVIORAL Cognitive Enhancement Therapy
- BEHAVIORAL Enriched Supportive Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2012-06 |
| Est. Completion | 2018-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01561859
The ClinicalTrials.gov registry entry for NCT01561859 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Enhancement Therapy is the first listed.
NCT01561859 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01561859 about?
NCT01561859 is a clinical study titled "Brain Imaging, Cognitive Enhancement and Early Schizophrenia". The proposed project is designed to examine the effects of cognitive rehabilitation on brain structure and function in a randomized trial of 102 early course schizophrenia patients treated for 18 months with either cognitive enhancement therapy (CET) or an Enriched Supportive Therapy (EST) control, ...
What is the current status of trial NCT01561859?
This trial is currently completed. It is a NA study. The enrollment target is 102 participants. The study started on 2012-06. Estimated completion is 2018-06.
What interventions are being tested in trial NCT01561859?
The interventions under investigation include: Cognitive Enhancement Therapy (BEHAVIORAL), Enriched Supportive Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01561859?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.